Poster

Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study

Download this poster to see how Certara used quantitative systems pharmacology (QSP) to translate ¹⁷⁷Lu-PSMA-617…

Certara2026 年 6 月 9 日

Poster

Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies

Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.

Certara2026 年 6 月 9 日

Blog

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

Explore how ICH M15 is shaping regulatory expectations for Model-Informed Drug Development (MIDD), including model…

Certara2026 年 6 月 9 日

Press Coverage

支持模拟孕妇用药剂量的理由

孕妇通常被排除在药物临床试验之外，这使得临床医生缺乏用药剂量的指导。Discover how…

Certara2026 年 6 月 9 日

Case Study

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

Certara’s drug development support enabled a positive scientific opinion from the EMA for acoziborole, a…

Certara2026 年 6 月 2 日

Webinar

Model Acceptance in Regulatory Submissions: Practical Strategies for Regulatory Success

Certara2026 年 6 月 1 日

Publication

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…

Dorottya Gui-Bodnar2026 年 5 月 28 日

Publication

尼拉帕利（Niraparib）群体药代动力学建模以评估不同吸收模型

This publication describes the development of an updated population pharmacokinetic (PopPK) model for niraparib, a…

Certara2026 年 5 月 21 日

Blog

Best Practices for pharma commercialization in market access

Learn best practices for your pharma commercialization strategy. See how to localize content in pharma…

Daria Lavrentev2026 年 5 月 12 日

On-Demand Webinar

BioSpace webinar: Streamlining Nonclinical Development with FDA NAMs

Learn how to apply FDA NAM guidance to streamline nonclinical development, support IND decisions, and…

Certara2026 年 5 月 8 日

Certara 服务

Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study

Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

支持模拟孕妇用药剂量的理由

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

Model Acceptance in Regulatory Submissions: Practical Strategies for Regulatory Success

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

尼拉帕利（Niraparib）群体药代动力学建模以评估不同吸收模型

Best Practices for pharma commercialization in market access

BioSpace webinar: Streamlining Nonclinical Development with FDA NAMs

订阅时事通讯

快捷链接

解决方案

联系我们